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The  objective  of  this  study  was to evaluate  organ-wise  toxicological  effects  of sesamol  and  determine
the  LD50 cut-off  value  and  GHS  category  following  acute  oral  toxicity  method  OECD  423.  An acute  oral
toxicity  study  was carried  out in female  C57BL/6  mice.  Observations  for physical  behaviour  and  measure-
ments  on  haematology,  biochemistry,  histology  of vital  organs  were  performed.  In addition,  genotoxicity
assessment  using  comet  and  micronuclei  assays  was also  performed.  Acute  toxicological  effects  were
observed  at 2000  mg/kg,  while  no  adverse  effects  observed  at 300  mg/kg.  The  effects  of  2000  mg/kg  were
manifested  as  severe  histopathological  changes  in  all organs  (femur,  spleen,  gastrointestine,  lungs,  heart,
kidney,  liver,  stomach  and  brain)  and excessive  DNA strands  breaks  occurred  in  femoral  bone  marrow
cells  and  splenocytes.  A  single  dose  of  sesamol  (2000  mg/kg,  body  weight)  caused  the  death  of  two  mice
(out of three)  within  2  h. Hence,  sesamol  is in GHS  category  4 (>300–2000)  with  LD50 cut-off  value  ofistopathology
aematology
500  mg/kg  body  weight.  In contrast,  this  study  is  correlated  with  the  obtained  GHS  category  4 and  LD50
cut-off  value  580  mg/kg  body  weight  by  ProTox.  In  conclusions,  the  present  study  has  classiﬁed  sesamol
toxicity  and assessed  organ-wise  acute  oral  toxicity  of  sesamol  in  female  C57BL/6  mice.  Therefore,  these
ﬁndings  may  be  useful  for the  selection  of  dosages  for further  pre-clinical  evaluation  and potential  drug
developmental  of  sesamol.
©  2016  Published  by  Elsevier  Ireland  Ltd.  This is an  open  access  article  under the CC  BY-NC-ND. Introduction
Oxidative stresses have been implicated as causative agents in
arious disorders such as hepatic ﬁbrosis [34], pulmonary inﬂam-
ation [33], cardio vascular disorders [8], diabetic complication
13], renal disease [3,38,42], cancer radiation syndrome [43], sev-
ral neurodegenerative disorders [45] and the aging process [12].
hus, antioxidants that scavenge free radicals and reactive oxygen
pecies may  be considerable potential in ameliorating these disease
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processes. In the past few years, natural and endogenous antioxi-
dants have created considerable research interest for prevention or
amelioration of these diseases.
Sesamol (3,4-methylenedioxyphenol), is an important con-
stituent of sesame oilseed and is well-known for its nutritional and
medicinal value. It is used in ancient Chinese and Indian ayurvedic
medicine for various health problems. The antioxidant proper-
ties have been attributed to a number of polyphenolic substances
including sesamolin and sesamin [4]. Sesamol, possess good antiox-
idant activity due to a benzodioxole group, which is known to
scavenge hydroxyl radical and also produces another antioxidant
1,2-dihydroxybenzene [23]. In a number of in-vitro and in-vivo
investigations, sesamol has been documented as direct free radical
scavenger and indirect antioxidant [17,18,32,35].
Sesamol is responsible for the stability of sesame oil [1], and
is an efﬁcacious potential antioxidant and free radical scavenger
the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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n comparison to many reference antioxidant molecules [27,28].
s a result of its marked stability sesame oil is used as vehicle for
at-soluble substances in pharmaceuticals and in food industry. In
arious in-vivo models, sesamol has shown some efﬁcacy in differ-
nt diseases such as pulmonary inﬂammation [6,7], anti-platelet
5], cardio vascular disorders, diabetes, diabetic nephropathy [22],
enoprotective [14], hepatoprotective [41], cancer and mutagen-
sis [19], radioprotection [18,20,27,30,32,35,37], anticandidal [2],
eurodegenerative disorders [39], and the anti-aging process [40].
esamol activates cAMP-PKA signaling, inhibits the NF-B-PLC-
KC cascade thereby leading to inhibition of [Ca2+] immobilization
nd platelet aggregation. Therefore, sesamol appears to be hav-
ng implications for treatment of cancer and various inﬂammatory
iseases in addition to thromboembolic disorders [5].
Additionally, sesamol has properties to inhibit radiation induced
icronuclei, dicentric frequencies, thiobarbituric acid reactive sub-
tances, DNA strands breaks [24] and also enhances glutathione
GSH), superoxide dismutase (SOD), catalase (CAT) and glu-
athione peroxidase (GPx) in a concentration dependent manner in
rradiated cultured human lymphocytes [35]. Further, sesamol pre-
reatment inhibits radiation-induced lymphocytes DNA strands
reaks, lipid peroxidation and enhances the level of antioxidant
nzymes (GSH, GST, catalase) to reduce lethality in irradiated mice
17,18,32]. In earlier studies, our research group has evaluated
etailed antiradical properties of sesamol and found strong radical
cavenging properties in comparison to other reference antioxi-
ant molecules [27,28]. In addition, in-vitro studies using a V79
ell line, plasmid (pBR322) and calf thymus DNA, showed 20 times
igher protection and greater DMF  (dose modifying factor) than
elatonin, possibly be due to its strong free radical scavenging
roperty [27]. In continuation of these promising results, we have
lso reported that sesamol pre-treatment protects hematopoietic
ystems by reducing radiation-induced micronuclei frequencies,
otal chromosomal aberration and DNA strands breaks in mice
one marrow cells [24]. In another study, we have reported that
esamol pre-treatment protects hematopoietic system by reduc-
ng radiation-induced femoral hematopoietic progenitors stem cell
epletion, and loss of B cells and T cells sub-population and apo-
tosis in the spleen [20]. In that study, we reported that sesamol
re-treatment protected the gastrointestinal system by enhancing
rypt cell regeneration and inhibited lipid peroxidation, gut bacte-
ial translocation to spleen, liver and kidney probably by controlling
he expression pattern of p53, Bax and Bcl-x in irradiated mice
20]. These studies have revealed that sesamol is also a promising
adioprotector candidate for medical and unanticipated radiation
xposure.
Furthermore, bio-distribution and pharmacokinetics of sesamol
as been reported and is shown to be distributed in all vital organs
16], desirable for making it a candidate for drug development for
arious disorders related to single or multi-organ systems. But, the
ack of toxicity study is a major impediment for further develop-
ent of this promising candidate for different applications. The
bjective of this study, therefore, was to investigate toxicity of
esamol as per the acute toxic class method, OECD-423 guideline
n C57BL/6 female mice.
. Materials and methods
.1. Animal care and husbandry
Female C57BL/6 mice (8–10 week-old) weighing 22 ± 2 g were
andomly distributed divided into different groups and acclima-
ized for one week. Animals were housed in polypropylene cages
ontaining certiﬁed paddy husk as bedding, and maintained on
tandard diet (Lipin, India) and acidiﬁed water ad libitum in theorts 3 (2016) 880–894 881
animal house of the institute. The temperature and humidity were
maintained at 22 ± 2 ◦C and 50% humidity under a 12-h light/dark
cycles respectively. All protocols used in this experiment were
approved by the Institutional Animal Ethics Committee. The Insti-
tutional Ethical Committee number under which this study was
performed is INM/IEAC/2012/06. All efforts were made to minimize
suffering during sacriﬁce of animal through cervical dislocation.
2.2. Experimental design
The mice were randomly divided into 4 groups, of 3 mice each
as follows: Twelve-mice were divided randomly into four equal
groups based on the OECD-423 guideline.
Group-I: Control group animals received no treatment.
Group-II: Sesamol 2000 group animals received 2000 mg/kg
body weight of freshly prepared sesamol.
Group-III: Sesamol 300 group animals received 300 mg/kg body
weight of freshly prepared sesamol.
Group-IV: Sesamol 300 conﬁrmatory group animals received
300 mg/kg body weight of freshly prepared sesamol.
2.3. Sesamol preparation and administration
Sesamol (CAS No.: 533-31-3; Purity: 98%, Sigma-Aldrich, USA)
was freshly prepared as a suspension in analytical grade water with
1% carboxymethylcellulose (CMC; Merck, Germany) as vehicle. A
single dose of sesamol (either 300 or 2000 mg/kg) in a volume of
400 l was  administered orally using a canula (No. 16). The feed
to mice was  withheld, but not water for 3–4 h prior to sesamol
administration. A starting dose of 2000 mg/kg was selected and
orally administered to 3 mice (Group II) and observed for clini-
cal signs and mortality. After observing the immediate deaths of
all mice, a lower dose of 300 mg/kg body weight was  adminis-
tered to group III. When there were no signs of mortality observed,
another 300 mg/kg dose was  administered to group IV. Group I was
administered with 400 l vehicle as control.
2.4. Physical observation
The animals were closely observed for the ﬁrst 30 min  and
intermittently for 4-h to 24-h, and then for 14 days after drug
administration or until death for signs of acute toxicity, includ-
ing convulsions, lacrimation, salivation, urination, defecation pain,
distress, physical appearance and behavioural signs. The animals
showing signs of severe toxicity were humanely sacriﬁced. Body
weight was taken every day for 14 days.
2.5. Histopathological examination
To evaluate the toxicological alterations induced by sesamol
in vital organs (femur, spleen, gastrointestines, lungs, heart, kid-
ney, liver, stomach and brain), mice were sacriﬁced by cervical
dislocation and organs of interest were dissected out, cleaned in
pre-chilled PBS and ﬁxed in 10% formalin (v/v) at room tempera-
ture, as described earlier [21]. Brieﬂy, ﬁve-micron thick sections
were cut and placed on pre-cleaned slides. The sections were
stained with haematoxylin and eosin (H & E), mounted and ana-
lyzed using an upright motorized compound microscope with DIC
attached and a digital imaging system (Axio, Imager M2,  Zeiss,
Germany). Both the qualitative as well as quantitative (gastroin-
testine) changes in organs were assessed. To avoid bias in analysis,
all slides were independently coded before scoring and decoded
after completion of analysis.
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.6. Biochemical analysis in blood plasma
Blood was collected through cardiac puncture using a 23-G
eedle with disposable 1 ml  syringe into K2-EDTA vials (BD micro-
ainer, San Diego, CA, USA). Plasma was separated by centrifugation
t 2000g for 15 min  in refrigerated centrifuge (4 ◦C) and stored at
80 ◦C. Biochemical parameters related to kidney (Urea and Crea-
inine) and liver (AST, ALT, LDH and TRIGS) function were analyzed
ollowing manufacturer‘s protocol (Randox, United Kingdom) using
 biochemistry analyzer (Rx Monza, Randox, United Kingdom). All
equired calibration standards were performed before measure-
ents.
.7. Blood haematological analysis
Blood was collected by cardiac puncture using a 23-G nee-
le and 1 ml  disposable syringe, and about 100 l blood was
ransferred into K2-EDTA vials (BD microtainer, San Diego, CA,
SA) for haematology measurements. All haematological param-
ters (WBC, RBC, HGB, HCT, MCV, MCH, PLT, LY%, GR% RDW, PCT,
PV, PDW) measurements were made following manufacturer’s
rotocol (NIHON-KOHDEN, Japan) using an automated haematol-
gy analyzer (Celtac-alpha, NIHON-KOHDEN, Japan). All required
alibration standards were performed before measurement. The
aematology analyzer was maintained in accordance with the
xternal quality control of Randox.
.8. Neutral comet assay in bone marrow and splenocytes
Femur and spleen was removed after cervical dislocation/death,
leaned of extra fat tissue and minced using frosted slides (for
pleen) in petri dishes and ﬂushed out bone marrow using a 26-G
eedle with syringe (for femur) in falcon tubes. Single cells sus-
ensions were obtained by ﬁltration with a 100 M nylon mesh
trainer (BD Biosciences, San Diego, CA, USA). In spleenocytes,
BCs were lysed using lysis buffer (BD Biosciences, San Diego,
A, USA). The cell density (1 × 106 cells/ml) was assessed using a
aemocytometer (Neubauer, Marienfeld, Germany) and inverted
icroscope (4200, Meiji, Japan).
A neutral comet assay was performed to assess the DNA strand
reaks in bone marrow and splenocytes [31]. Brieﬂy, single cell
uspensions (4 × 104 cells) were mixed with 0.7% (w/v) low-
elting-point agarose and immediately pipetted onto a pre-coated
omet slide with 1% (w/v) normal-melting-point agarose. The slides
ere transferred onto slide tray resting on ice packs to harden the
garose layer (at least 10 min) and then immersed in a lysing solu-
ion (2.5% sodium dodecylsulfate, 1% sodium sarcosinate, 25 mM
a2EDTA, pH 9.5) containing 10% (v/v) DMSO for 15 min  at RT. Fur-
her, slides were removed and placed side-by-side in a comet-20
ystem (Scie-Plas, Cambridge, England) ﬁtted with a refrigerated
ater circulator (Julabo F12, Germany). The slides were immedi-
tely covered with freshly prepared neutral electrophoresis buffer
90 mM Trizma base, 90 mM Boric Acid, 2.5 mM Na2-EDTA, pH 8.3)
nd electrophoresed (2 V/cm) using an electrophoresis power sup-
ly (Consort EV261, Belgium) for 7 min  at 10 ◦C. After completion of
lectrophoresis, slides were washed with water and dried at 50 ◦C.
hen convenient, slides were stained with 2.5 g/ml propidium
odide and at least 500 comet cells were scored for each mouse
sing an automated MetaCyte Comet Scan system (Metafer4, Zeiss,
ermany).
.9. Micronucleus assay in femoral bone marrow cellsBone marrow cells were processed for micronuclei assessment
rom each mouse as described earlier [24]. Brieﬂy, after washing the
one marrow cells were smeared on clean dry microscopic slide.orts 3 (2016) 880–894
Slides were stained with cocktail of May—Grunewald and Giemsa
solution. After staining the slides were mounted with DPX mount-
ing solution and coded by independent person to avoid scorer bias
in cell scoring. A minimum of 1000 polychromatic erythrocytes
(PCE) were scored along with normochromatic erythrocytes (NCE)
from each mouse to calculate the micronuclei frequency in both PCE
and NCE. The ratio of PCE and NCE was  also calculated to assess
the status of cell proliferation. All cytogenetic slides were coded
by a person not involved with this study and then analyzed. After
completion of all analyses, slides were decoded.
2.10. Body and relative organ mass
Body weights of individual mouse were taken before and after
fasting, and average body weight was  used. Individual organs were
excised and cleaned with cold PBS and weighed. The relative organ
weights of individual mice were calculated as given below.
Relative Organ Weight (ROW) = Organ Weight (mg)/body Weight (g).
2.11. In silico prediction of rodent oral toxicity
Acute oral toxicity of sesamol in rodent was  predicted by Pro-
Tox web server [9]. Sesamol toxicity was predicted as LD50 (mg/kg)
values and categorised by globally harmonized system of classiﬁca-
tion of labelling of chemicals (GHS). Pharmacophore search based
sesamol similar compounds were identiﬁed having known LD50.
2.12. Statistical analysis
The mean values and standard errors of the data were ana-
lyzed and reported. Pairwise comparisons were made between two
groups using Student‘s t-test. Signiﬁcant differences among groups
were consider if p < 0.05.
3. Results
3.1. Physical observations
The animals were observed for ﬁrst 30 min  and thereafter inter-
mittently for 4 h to 24 h, and then daily for 14 days, after drug
administration for signs of acute toxicity. The 2000 mg/kg dose
group showed acute toxicity characterized by severe convulsions
within 2–5 min  of drug administration, with lacrimation, urination,
wheezing sounds and apnoea leading to death. The ﬁrst mouse
died within 30 min  of sesamol administration, other two  mice were
humanely sacriﬁced after similar signs of acute toxicity.
The C57BL/6 mice at 300 mg/kg showed slight jerking move-
ment/convulsions with laboured breathing and rales, no signs of
severe toxicity. All groups i.e.,  I, III, IV were observed daily for
body weight changes, physical and behavioural signs such as:
mucus from nostrils, laboured breathing, rales, vocalization on han-
dling and aggressiveness. Such behavioural signs were absent in
300 mg/kg of sesamol treated mice. The animals were observed
once daily for 14 days and no abnormal behaviour was observed
other than vocalization and aggressiveness in 1–2 mice in groups
III and IV on day 1 and 2. Body weights were recorded for 14 days,
and no adverse changes were seen.
3.2. Determination of LD50 cut-off value and classiﬁcation
according to GHS
A single dose of 2000 mg/kg of sesamol administered to three
mice resulted in the death of all the three mice within 2-h after
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dministration. The next dose, 300 mg/kg, resulted in no deaths of
ice within the period of 14 days observation. The conﬁrmatory
ose of 300 mg/kg of sesamol was also orally administered to three
ice and resulted in no fatalities of mice within the period of 14 day
bservations. Therefore, sesamol was placed in GHS category IV
>300–2000) with LD50 cut-off value of 500 mg/kg according to the
ECD-423 guideline.
.3. Gross histopathological changes in vital organs
Sesamol showed cellular toxicity in all organs examined at the
igher dosage (2000 mg/kg). Both qualitative and quantitative (gas-
rointestine) analyses were performed to assess the level of cellular
oxicity. Qualitative analysis revealed cellular toxicity (in terms
f apoptosis, necrosis, depopulation and other parameters) in all
ajor organs at higher dose (2000 mg/kg) (Figs. 1–9 ). The lower
ose of sesamol (300 mg/kg) had no apparent effect on organ cel-
ular toxicity (Fig. 1–9).
.4. Toxicological effect of sesamol on bone marrow cellularity
Bone marrow is one of the largest organs in the body and is
 major hematopoietic organ responsible for the production of
rythrocytes, granulocytes, monocytes, lymphocytes and platelets
10]. Assessment of bone marrow, therefore, is frequently a rou-
ine procedure for the investigation of haematological disorders
n toxicity and safety related studies. In addition, morphological
ssessment of bone marrow tissue sections provides informa-
ion regarding their histological architecture such as cellularity,
nﬂammation and necrosis. Thus, in the present study we  have
erformed qualitative analysis of bone marrow. Sesamol group II
2000 mg/kg) indicated severe changes in the histological architec-
ure, which were characterized by the severe loss of cellularity and
xtensive depopulation of lymphoid cells (Fig. 1C and D). While
roups III and IV of sesamol (300 mg/kg) did not cause any changes
n the bone marrow cellularity and revealed similar histological
rchitecture of bone marrow in comparison to control (group I)
Fig. 1A and B).
.5. Toxicological effects of sesamol on splenic histopathological
lteration
Qualitative analysis in Group II of sesamol (2000 mg/kg) treated
ice showed loss of cellularity and depopulation of lymphocytes,
haracterized by necrosis/apoptosis in lymphoid cells (Fig. 2C and
). The lower dose (300 mg/kg) showed no cellular toxicity (Fig. 2B)
nd appeared similar to control (Fig. 2A).
.6. Histopathological alteration in gastrointestinal tract by
esamol
Both qualitative and quantitative analysis was performed to
ssess the effect of sesamol toxicity in epithelial stem cells. Analy-
is of sesamol group II (2000 mg/kg) treated mice showed extensive
oss of epithelial stem cells and villi shrinking (Fig. 3C and D) result-
ng in signiﬁcantly decreased crypts numbers and villi numbers
nd length (Fig. 3C and D). Normal histological architecture of gas-
rointestinal tract was observed in both the control and sesamol
300 mg/kg) treated mice (Fig. 3A). Quantitative analysis of gas-
rointestinal tissue also revealed and supported the extensive loss
n the stem cell region of gastrointestine, which were measured
y counting the crypts and villi numbers. The data presented in
ig. 3D–F clearly show a signiﬁcant decrease in the numbers of
rypts and villi of 2000 mg/kg treated mice.orts 3 (2016) 880–894 883
3.7. Sesamol-induced histopathological changes in stomach
The animals treated with the higher dose of sesamol
(2000 mg/kg) revealed severe loss of gastric pits, isthmus and neck,
base and extensive ruptured mascularis mucosa, such effect were
completely absent in the lower dose of sesamol (300 mg/kg) treated
mice (Fig. 4B–D).
3.8. Toxicological effect of sesamol on liver histology
Qualitative analysis of the liver of 2000 mg/kg treated mice
showed swelling and degenerative changes followed by necrosis
and dilated tubules (Fig. 5C and D), which were completely absent
in 300 mg/kg treated mice (Fig. 5B).
3.9. Histopathological changes in kidney after sesamol treatment
The qualitative analysis of the kidneys of 2000 mg/kg treated
mice showed swelling, focal degeneration and dilated tubules
(Fig. 6C and D). Whereas, the kidneys of 300 mg/kg treated mice
showed normal histological architecture of the glomerulus and
Bowman’s capsule (Fig. 6B).
3.10. Effect of sesamol treatment on the histology of the heart
The heart of control mice showed normal architecture of
myocardial ﬁbers (Fig. 7A). Extensive degeneration, fragmentation
and hyalinization of myocardial ﬁbers with congested blood ves-
sel were observed in 2000 mg/kg treated mice, such effects were
absent in 300 mg/kg treated mice (Fig. 7B).
3.11. Sesamol-induced histopathological alteration in lungs
The lung tissue of control mouse showed normal structure of
alveoli with intra-alveolar septa (Fig. 8A). The lungs of mice treated
with the higher dose of sesamol (2000 mg/kg) showed extensive
emphysema and focal ﬁbrosis of the alveoli with ruptured alveo-
lar walls. In addition, haemorrhage with degeneration of alveoli
was also detected in the higher dose of sesamol treated mice
(Fig. 8C and D). Whereas, the lower dose of sesamol (300 mg/kg)
revealed normal lungs and histological architecture, as showed
in Fig. 8B.
3.12. Toxicological effects of sesamol on brain histology
In the brain of mice treated with the higher dose of sesamol
(2000 mg/kg), severe neuronal degeneration followed by vacuolar
changes was  observed (Fig. 9C and D). The lower dose of sesamol
(300 mg/kg) revealed a normal complexity of the brain similar to
control (Fig. 9A and B).
3.13. Toxicological effects of sesamol on liver and kidney function
Urea and creatinine were measured to assess kidney function
test (Fig. 10), whereas, AST, ALT, LDH and TRIGS were measured to
assess the liver function test (Fig. 11).
3.13.1. Biochemical test for liver function
Liver function test were conducted in sesamol 300 mg/kg and
compared to control group and found to be similar. At300 mg/kg
and in the control group AST was  74 U/l and 71.80 U/l, respec-
tively; though ALT was insigniﬁcantly increased (P > 0.05) from
35.65 U/l in control to 47.55 U/l in 300 mg/kg group, and LDH activ-
ity was  slightly decreased in 300 mg/kg group from 498.39 to
361.10 U/l (P > 0.05). The level of triglycerides was signiﬁcantly
decreased ((P < 0.05) from 57.20 mg/dl in control to 30.30 mg/dl
884 S. Khan et al. / Toxicology Reports 3 (2016) 880–894
Fig. 1. Toxicological effect of sesamol in mice bone marrow cellularity. Femur was collected after cervical dislocation. After ﬁxation, processing and dehydration, cross
sections of femur (5 m)  were stained with H&E. Representative photographs for femur are shown (original magniﬁcation and 400×). Panel A: control, femur showing
normal cellular architecture; Panel B: sesamol—300 mg/kg, femur showing normal cellular architecture; Panel C and D: sesamol—2000 mg/kg, femur showing extensive loss
of  cellularity (red arrow) and depopulation (yellow arrow) of the lymphoid cells. (Original magniﬁcation 400×).
Fig. 2. Toxicological effects of sesamol in mice splenic histopathological alteration. Spleen was  collected after cervical dislocation. After ﬁxation, processing and dehydration,
c hs for
n al cel
c . (Orig
i
p
(ross  sections of jejunum (5 m)  were stained with H&E. Representative photograp
ormal cellular architecture; Panel B: sesamol—300 mg/kg, spleen showing norm
ellularity (C) (red arrow) and depopulation (D) (yellow arrow) of the lymphocytesn 300 mg/kg group (Fig. 10). All the control values of measured
arameters were in range similar to reported in literature [11]
Fig. 10). spleen are shown (original magniﬁcation 400×). Panel A: control, spleen showing
lular architecture; Panel C and D: sesamol—2000 mg/kg, spleen showing loss of
inal magniﬁcation 400×).3.13.2. Biochemical test for kidney function
In the 300 mg/kg sesamol and control groups, urea was found
to be 30.70 mg/dl and 29.00 mg/dl, respectively, whilst creatinine
was insigniﬁcantly increased (P > 0.05) from 0.47 mg/dl in control
S. Khan et al. / Toxicology Reports 3 (2016) 880–894 885
Fig. 3. Histopathological alteration in mice jejunum crypt number, villus number and length by sesamol treatment. Jejunum were collected after cervical dislocation.
After  ﬁxation, processing and dehydration, cross sections of jejunum (5 m)  were stained with H&E and crypt number, villus number and villus height were analyzed.
Representative photographs for crypt number, villus number and villus height are shown (original magniﬁcation 100×). Panel A: control/sesamol—300 mg/kg, showing
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tormal gastrointestinal architecture; Panel C: sesamol—2000 mg/kg, showing ruptu
etween groups; Panel E: comparison of mean villi length between groups; Panel F
o 0.66 mg/dl in sesamol 300 mg/kg (Fig. 11). The control values of
ll parameters were found to be in range as reported earlier [11]
Fig. 11).
.14. Toxicological effects of sesamol on blood haematological
hanges
The higher dose of sesamol (group II) signiﬁcantly increased the
lood parameters RBCs, HGB, HCT, LY%, MPV  and decreased GR%
n comparison to control (group I) (Table 1). Whereas, the lower
ose of sesamol (group III and IV) did not cause any changes in
he haematological parameters, and the values of haematological
arameters were near to the corresponding control mice (group I)
Table 1)..15. Toxicological effects of sesamol on DNA strand breaks
The higher dose of sesamol group II (2000 mg/kg) was  found
o extensively increase DNA strands breaks parameters (taililli tips and distorted villi and crypts. Panel D: comparison of mean crypt numbers
parison of mean villi numbers between groups. *p < 0.05.
length, tail moment, olive moment and% DNA in tail) in both
the marrow cells and spleenocyte in comparison to control
(Figs. 12 and 13). Whereas, the lower dose of sesamol groups
III and IV (300 mg/kg) did not cause DNA strands breaks; all
DNA strands break parameters were similar to control mice
(Figs. 12 and 13).
3.16. Toxicological effects of sesamol on the formation of
micronuclei
The higher dose of Sesamol group II (2000 mg/kg) caused
death within two hours, therefore, no micronuclei formation was
observed. The result showed that frequency of mnPCE/1000 PCE
(11.30 ± 0.41) in sesamol group II (2000 mg/kg) treated animals was
almost similar to control mice (group I) (6.82 ± 1.92). The mnPCE
frequency in sesamol group III & IV (300 mg/kg) treated animals
(10.46 ± 2.25) was also near to control mice (group I) (Fig. 14).
The difference between frequencies of mnPCE in all the groups
was non-signiﬁcant (p > 0.05). The proportion of immature (PCE)
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Fig. 4. Sesamol-induced histopathological changes in mice stomach. Stomach was collected after cervical dislocation. After ﬁxation, processing and dehydration, cross
sections of stomach (5 m)  were stained with H&E and gastric pits, isthmus and neck, base as well as mascularis mucosa were analyzed. Representative photographs for
stomach are shown (original magniﬁcation 100×). Panel A: control, stomach showing normal cellular architecture; Panel B: sesamol—300 mg/kg, stomach showing normal
cellular  architecture; Panel C and D: sesamol—2000 mg/kg, stomach showing almost complete loss of gastric pits (red arrow), isthmus and neck (yellow arrow), base (black
arrow) and extensive ruptured mascularis mucosa (green arrow). (Original magniﬁcation 100×).
Fig. 5. Toxicological effect of sesamol in mice liver histology. Liver was collected after cervical dislocation. After ﬁxation, processing and dehydration, cross sections of jejunum
( inal m
P  C and
a (black
a
t
c5  m) were stained with H&E. Representative photographs for liver are shown (orig
anel  B: sesamol—300 mg/kg, liver showing normal histological architecture; Panel
rrow),  necrotic hepatocytes near the central vein (red arrow), dilated central vein long with mature (NCE) erythrocytes was determined to study
he cellular toxicity and proliferation inhibition of bone marrow
ell. The results showed that the PCE/NCE ratio was also not sig-agniﬁcation 400×). Panel A: normal. Liver showing normal histological architecture;
 D: sesamol—2000 mg/kg, liver showing periportal lymphocytic inﬁltration (yellow
 arrow). (original magniﬁcation 400×).niﬁcantly (p > 0.05) different in all groups of sesamol treated mice
(group II–IV) in comparison to control mice (group I) (Fig. 14). In
the present study, therefore, the results suggest that neither the
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Fig. 6. Histopathological changes in mice kidney after sesamol treatment. Kidney was  collected after cervical dislocation. After ﬁxation, processing and dehydration, cross
sections of jejunum (5 m)  were stained with H&E. Representative photographs for kidney are shown (original magniﬁcation 400×). Panel A: Normal. Kidney showing
normal histological architecture of renal carpuscles with its glomerulus (G) and Bowman‘s capsule (BC); Panel B: sesamol—300 mg/kg, kidney showing normal histological
architecture; Panel C and D: sesamol—2000 mg/kg, kidney showing swelling (red arrow), focal degeneration (yellow arrow) and dilated tubules (black arrow). (Original
magniﬁcation 400×).
Fig. 7. Effect of sesamol treatment in histology of mice heart. Heart was  collected after cervical dislocation. After ﬁxation, processing and dehydration, cross sections of
heart  (5 m)  were stained with H&E. Representative photographs for heart are shown (original magniﬁcation 400×). Panel A: Normal. Heart showing normal histological
architecture; Panel B: sesamol—300 mg/kg, heart showing normal histological architecture; Panel C and D: sesamol—2000 mg/kg, heart showing extensive degeneration,
fragmentation and hyalinization of muscle ﬁbers (H) with congested blood vessel (red arrow). (original magniﬁcation 400×).
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Fig. 8. Sesamol-induced histopathological alteration in mice lungs. Lung was  collected after cervical dislocation. After ﬁxation, processing and dehydration, cross sections of
lung  (5 m) were stained with H&E. Representative photographs for lung are shown (original magniﬁcation 100×). Panel A: Control, lung showing normal cellular architecture;
Panel  B: Sesamol—300 mg/kg, lung showing normal cellular architecture; Panel C and D: Sesamol—2000 mg/kg, lung showing extensive emphysema and focal ﬁbrosis of the
alveoli with ruptured alveolar walls (red arrow), and haemorrhage with degeneration of alveoli (yellow arrow). (Original magniﬁcation 100×).
Fig. 9. Toxicological effects of sesamol in mice brain histology. Brain was collected after cervical dislocation. After ﬁxation, processing and dehydration, cross sections of brain
( iginal
P  and D
a
h
s
o5  m) were stained with H&E. Representative photographs for brain are shown (or
anel  B: sesamol—300 mg/kg, brain showing normal cellular architecture; Panel C
nd  vacuolar changes (yellow arrow). (Original magniﬁcation 100×).igher dose of sesamol 2000 mg/kg (group II) nor lower dose of
esamol 300 mg/kg (group III and IV) was able to induced formation
f micronuclei in bone marrow cells. magniﬁcation 100×). Panel A: Control, brain showing normal cellular architecture;
: sesamol—2000 mg/kg, brain showing severe neuronal degeneration (red arrow)3.17. Toxicological effects of sesamol in relative organ weight
The higher dose of sesamol (2000 mg/kg) did not cause any sig-
niﬁcant changes in spleen, lungs, heart, kidney, stomach and brain
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Fig. 10. Effect of sesamol (300 mg/kg body weight) on liver function. AST, ALT, LDH and T
*p  < 0.05.
Fig. 11. Effect of sesamol (300 mg/kg body weight) on kidney function. Urea and
c
o
(
s
3
L
v
(
a
be correlated with the acute effects in respiratory system.reatinine were measured in blood plasma as described in materials and method-
logy.
except liver) in comparison to control (Fig. 15). The lower dose of
esamol (300 mg/kg) value was similar to control mice (Fig. 15).
.18. In silico prediction of sesamol oral toxicity in rodent
Sesamol can be placed under class 4 category and predicted
D dose was found to be 580 mg/kg body weight. The LD50 50
alue revealed that sesamol would be harmful if swallowed
300 < LD50 ≤ 2000 mg/kg). Based on pharmacophore search the
verage similarity and prediction accuracy of sesamol are 76.07%RIGS were measured in blood plasma as described in materials and methodology.
and 69.26%, respectively. However, three compounds similar to
sesamol were identiﬁed (Table 2).
4. Discussion
Herbal derived medicines are gaining importance, it is there-
fore necessary to establish safety, toxicity, and efﬁcacy and quality
data in accordance with regulatory guideline. Sesamol has already
shown efﬁcacy in various preclinical models, and appeared to be
a potential drug candidate [17,18,32,35,24,20]. Toxicity studies
on sesamol have not been extensively studied in accordance to
internationally recognized OECD guidelines. In the present study
we have investigated the toxicity of sesamol in female C57BL/6
mice following the OECD-423 guideline. The study presented here
considers the GHS classiﬁcation of sesamol as a GHS 4 category
molecule.
Ambrose et al. [1], conducted toxicological studies with rodents,
non-human primates and human volunteers, and demonstrated
that sesamol was  non-irritant to the skin and did not cause skin
sensitization. This study mad  several observations, (i) injection of
aqueous solution equivalent to 5 mg/kg of sesamol through the
intra-dermal route developed necrosis at the site of injection within
4 days in six rats out of ten, (ii) injection of aqueous solution equiv-
alent to 50 mg/kg the through intra-dermal route for 4 days in three
rabbits did not cause local or systemic effects, (iii) sesamol doses
of 1.2, 2.3 and 4.6 mg/kg was administered to six rabbit each dose
in the conjunctiva sac and found oedema of the nictitating mem-
brane, swelling of the palpebral folds and conjunctivitis within 4-h,
whereas, relatively all mice appeared near to normal after 48-h.
Ambrose et al. also reported forestomach tumours due to chronic
administration of sesamol. In addition, consolidation and inﬂam-
matory changes were observed in lungs [1]. In the present study,
physical observation as congestive atelexacis and histopathologi-
cal changes in lungs revealed an acute inﬂammatory inﬁltrate, and
decreased PCV in haematological measurements and therefore canIn this study, we  have found a higher dose of sesamol
(2000 mg/kg) induced severe histopathological changes in all vital
organs, which were characterized by (i) loss of cellularity and
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Fig. 12. Effect of sesamol on DNA double strands breaks in femoral bone marrow of mice. A neutral comet assay was performed to analyzed DNA strands breaks as described
in  materials and methodology. DNA strands breaks are represented as tail length, tail moment, olive moment and% DNA in tail. *p < 0.001.
F tral c
a olive m
e
s
eig. 13. Effect of sesamol on DNA double strands breaks in splenocytes of mice. A neu
nd  methodology. DNA strands breaks are represented as tail length, tail moment, xtensive depopulation of lymphoid cells in femur (ii) necro-
is/apoptosis of lymphoid cells in spleen, (iii) extensive loss of
pithelial stem cells and villi shrinking in gastrointestine, (iv)omet assay was  performed to analyzed DNA strands breaks as described in materials
oment and% DNA in tail. *p < 0.0001.severe loss of gastric pits, isthmus and neck, base as well as
extensive ruptured mascularis mucosa in stomach, (v) swelling,
degeneration, necrosis and dilated tubules in liver, (vi) swelling,
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Table 1
Sesamol-mediated haematological modulation.
Groups Statistics Haematological Parameters
WBC  (103/l) RBC (106/l) HGB (g/dl) HCT (%) MCV (ﬂ) MCH (pg) MCHC (g/dl) PLT (103/l) LY (%) GR (%) RDW (%) PCT (%) MPV (ﬂ) PDW (%)
Control Mean 5.37 8.81 12.77 40.03 45.5 14.5 31.75 782.67 73.47 26.53 13.5 0.27 3.47 18.23
SD 0.65 0.58 0.47 1.44 1.51 0.53 0.21 19.04 3.27 3.27 0.1 0.01 0.06 0.75
Ses 2000 0–2h Mean 6 10.5a 15.8a 49.33b 46.83 15 31.7 805 80.57b 19.43b 13.57 0.27 5.1 20.07a
SD 2.07 0.17 0.35 0.58 1.19 0.4 0.42 66.47 3.44 3.44 0.12 0.1 1.66 0.46
Ses 300 14 day Mean 4.88 9.07 13.62 41.6 45.9 15.02 32.72 767 72.25 27.68 13.82 0.27 3.46 19.32
SD  1.16 0.23 0.26 0.85 0.87 0.42 0.4 150.08 3.58 3.1 0.46 0.04 0.09 0.3
Statistical signiﬁcant difference between Control and Sesamol 2000 mg/kg body weight groups.
a P < 0.05.
b P < 0.01.
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Table 3
Physio-chemical properties of sesamol.
Sl No. Physio-Chemical
Properties
Sesamol
1 IUPAC 1,3-benzodioxol-5-ol
2 CAS No. 533-31-3
3 Formula C7H6O3
4 Synonyms Phenol,3,4-(methylenedioxy)-(7CI,8CI);
3,4-(Methylenedioxy) phenol;
4-Hydroxy1,2-methylenedioxybenzene;
5-Hydroxy-1,3-benzodioxole;
Benzodioxol-5-ol;NSC59256;
3,4-Methylenedioxyphenol
5 Appearance white to off-white crystalline
6  Molecular Weight 138.12 g/mol
7 Melting Point 6265 ◦C (l)
8  Boiling point 274 ◦C at 760 mmHg
9  Storage Temperature 20 ◦C
10  Flash Point 119.5 ◦C
11 Density 1.394 g/cm3
12  Water Solubility slightly soluble
13 Refraction Index 1.609
14 Molar Refractivity 34.29 cm3
15  Molar Volume 99 cm3
16 Surface Tension 61.7 dyn/cm
17 Vaporization Enthalpy 53.3 kJ/mol
18 Vapour Pressure 0.00331 mmHg at 25 ◦C
19  Lipophilicity (LogP) 1.2
20 H-Bond Donor 1
21 H-Bond Acceptor 3
Table 4
Sesamol’s Lipinski rule of ﬁve.
Sl. No. Lipinski Rule of Five Sesamol
1 Molecular mass (less than 500 Da) 138.121 g/mol
2  High lipophilicity (LogP less than 5) 1.121
caused by 2000 mg/kg of sesamol (group II). The sesamol induced92 S. Khan et al. / Toxicolo
ocal degeneration and dilated tubules in kidney, (vii) extensive
egeneration, fragmentation and hyalinization of myocardial ﬁbers
ith congested blood vessel in heart, (viii) extensive emphysema
nd focal ﬁbrosis of the alveoli with ruptured alveolar walls as
ell as haemorrhage with degeneration of alveoli in lung, (ix)
evere neuronal degeneration followed by vacuolar changes in
rain (Figs. 1–9).
Induction of DNA damage is considered as one of the important
nitial event in cellular toxicity. It is also well known that mecha-
isms of cellular toxicity involve DNA damage. The comet assay is a
ensitive method for detecting cellular DNA damage. In this study,
e have used the comet assay to assess the femoral bone marrow
ells and splenocytes cellular DNA damage after sesamol treatment.
e have found that sesamol induced extensive DNA damage in
000 mg/kg group within the 2 h in comparison to control group
Figs. 12 and 13). Whilst, the sesamol 300 mg/kg group showed
NA damage close to control group (Figs. 12 and 13). On the other
and, no such genotoxicity was observed using a micronucleus
ssay with sesamol at 2000 mg/kg (Fig. 14). The comet assay ﬁnd-
ngs together with histopathological observation in the femur and
pleen suggests that higher dose of sesamol (2000 mg/kg) appeared
o be very toxic at the level of DNA. The comet assay ﬁndings also
emonstrated that lower dose of sesamol (300 mg/kg) induced no
pparent effects on DNA (Figs. 12 and 13).
In addition, biochemical markers related to kidney (urea and
reatinine) and liver (AST, ALT, LDH and TRIGS) function were
easured in the sesamol (300 mg/kg) group and compared with
ontrol groups, similar results were seen (Figs. 10 and 11). Plasma
mino transferases such as ALT and AST indicate the concentra-
ion of hepatic intracellular enzymes that have leaked into the
irculation as a result of hepatocellular injury [15]. In this study,
evel of AST in 300 mg/kg group was comparable to normal con-
rol, while ALT was insigniﬁcantly increased (P > 0.05), indicative
f possibly low hepatoxicity. LDH activity was slightly decreased
P > 0.05) in 300 mg/kg group, which may  indicate possibly low
evel of liver insult. TRIGS were found to decrease signiﬁcantly
p < 0.05) in the sesamol 300 mg/kg group in comparison to control
roup. This was expected (i.e., decrease of TRIGS) because inhibi-
ion of cholesterol biosynthesis and increase of uptake of LDL from
lood by sesamol contained in sesamol oil, has been reported [36].
n case of deterioration of kidney function, urea and creatinine lev-
ls always increases in combination. In our study the levels were
imilar to control, suggesting that kidney function was not affected
y administration of the sesamol.
In order to assess toxicological effects of sesamol on blood
arameters a complete blood haematological measurements were
erformed in mice treated with sesamol (group II–IV) and com-
ared with control mice (group I). Analysis of data revealed that
nly sesamol group II (2000 mg/kg) has signiﬁcantly altered the
able 2
roTox predicted sesamol similar compounds.
Sesamol Sesamol similar compounds
Compound 1 
Formula C7H6O3 Formula C7H6O2
Molecular Weight 138.12 Molecular Weight 122.12 
Toxicity Class 4 Toxicity Class 4 
LD50  580 mg/kg LD50 580 mg/kg 3  Donors hydrogen bond (Less than 5) 1
4  Acceptors hydrogen bond (Less than 10) 3
5  Molar refractivity (Between 40–130) 34.29 cm3
level of RBCs, HGB, HCT, MPV, LY% and GR% (Table 1). The increased
value of RBCs, HGB, HCT, LY% and MPV  indicates drug toxicity which
could be because of apnea or pulmonary ﬁbrosis or due to poly-
cythemia [44]. The apnea was also observed as physical parameter
while monitoring the mice. Polycythemia is an apparent rise of the
erythrocyte level in the blood which may  be caused by reduced
blood plasma. Relative polycythemia is often caused by loss of
body ﬂuids, such as through dehydration and stress which may  beCompound 2 Compound 3
Formula C15H22O6 Formula C9H12N2O3
Molecular Weight 298.33 Molecular Weight 196.2
Toxicity Class 4 Toxicity Class 3
LD50 580 mg/kg LD50 580 mg/kg
increase in some of the haematological parameters is in accordance
with the toxicological studies [44]. The increase in PCV, HGB and
RBCs reported in this study to be associated with sesamol injec-
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ion may  be attributed to the reversal of bone marrow depression
ith attendant improvement in erythrocyte membrane stability.
oreover, sesamol has strong antioxidant properties and these
ntioxidant properties attributes to reduced haemolysis. However,
emur has shown severe loss of cellularity in the histological studies
espite that there was an increase in haematological parameters.
he reason could be that mice were sacriﬁced between 30 min  to 2 h
nterval and the effect of bone marrow depletion could not impact
he haematological outcome within 2 h [26,29].
ProTox; web server predicted sesamol GHS category 4 and LD50
ut-off value 580 mg/kg body weight in rodent [9] (Table 2). This
tudy is correlated with the obtained GHS category 4 and LD50 cut-
ff value 500 mg/kg body weight by following acute oral toxicity
ethod (OECD 423 guideline) in female C57BL/6 mice. Thus, both
n-vivo and in-silico studies provided similar acute oral toxicity of
esamol in rodent. In addition, we have also mentioned the sesamol
hysico-chemical properties (Table 3). The sesamol almost follow
he Lipinski rule of ﬁve (Table 4) [25]. The drugs that follow the
ipinski rule of ﬁve are likely to have decreased attrition during
linical trials.
. Conclusions
This study was conducted in accordance with the OECD-423
uideline. From the observations in the present study, sesamol
hould be placed under GHS category 4 (>300–2000) with LD50
ut-off value of 500 mg/kg in female C57BL/6 mice. This study also
emonstrated clear toxicological effects, biochemical changes and
enomical alterations induced by sesamol in female C57BL/6 mice.
hese ﬁndings could, therefore, can be helpful for the selection of
osages for pre-clinical in murine models and for additional stud-
es on sesamol in the drug developmental process. Further, toxicity
tudies and their validation using others animal models may be
arranted.
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